106 related articles for article (PubMed ID: 19118877)
1. Effect of uniform consensus recommendations for PCa screening in older population: differential effects and perceptions of healthcare providers and patients.
Konety BR; Raut H; Smith BJ; Sharp VJ; Williams RD
Urology; 2009 Mar; 73(3):603-8; discussion 608-9. PubMed ID: 19118877
[TBL] [Abstract][Full Text] [Related]
2. Practice patterns in screening and management of prostate cancer in elderly men.
Konety BR; Sharp VJ; Verma M; Williams RD;
Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
[TBL] [Abstract][Full Text] [Related]
3. Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus.
Konety BR; Sharp VJ; Raut H; Williams RD
Urology; 2008 Mar; 71(3):511-4. PubMed ID: 18342199
[TBL] [Abstract][Full Text] [Related]
4. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
6. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
Gerard MJ; Frank-Stromborg M
Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
[TBL] [Abstract][Full Text] [Related]
7. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer screening: knowledge, experiences and attitudes of men aged 40-79 years.
Arroll B; Pandit S; Buetow S
N Z Med J; 2003 Jun; 116(1176):U477. PubMed ID: 12835805
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts.
Davis TC; Humiston SG; Arnold CL; Bocchini JA; Bass PF; Kennen EM; Bocchini A; Kyler P; Lloyd-Puryear M
Pediatrics; 2006 May; 117(5 Pt 2):S326-40. PubMed ID: 16735260
[TBL] [Abstract][Full Text] [Related]
10. Patient attitudes toward screening.
Bonds DE; Ellis SD; Weeks E; Lichstein P; Burke K; Posey C
N C Med J; 2007; 68(1):23-9. PubMed ID: 17500428
[TBL] [Abstract][Full Text] [Related]
11. [An investigation of prostate cancer knowledge among Chinese city men].
Zhu G; Wang X; Yan W; Wang JL; Wan B
Zhonghua Nan Ke Xue; 2009 Feb; 15(2):149-52. PubMed ID: 19323376
[TBL] [Abstract][Full Text] [Related]
12. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives.
Sabatino SA; Habarta N; Baron RC; Coates RJ; Rimer BK; Kerner J; Coughlin SS; Kalra GP; Chattopadhyay S;
Am J Prev Med; 2008 Jul; 35(1 Suppl):S67-74. PubMed ID: 18541190
[TBL] [Abstract][Full Text] [Related]
13. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
14. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
[TBL] [Abstract][Full Text] [Related]
15. Physician, affective, and cognitive variables differentially predict 'initiation' versus 'maintenance' PSA screening profiles in diverse groups of men.
Consedine NS; Christie MA; Neugut AI
Br J Health Psychol; 2009 May; 14(Pt 2):303-22. PubMed ID: 18808732
[TBL] [Abstract][Full Text] [Related]
16. What motivates men age > or =50 years to participate in a screening program for melanoma?
Janda M; Youl PH; Lowe JB; Baade PD; Elwood M; Ring IT; Aitken JF
Cancer; 2006 Aug; 107(4):815-23. PubMed ID: 16832794
[TBL] [Abstract][Full Text] [Related]
17. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
18. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
Howard K; Barratt A; Mann GJ; Patel MI
Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes.
Brassell SA; Rice KR; Parker PM; Chen Y; Farrell JS; Cullen J; McLeod DG
J Urol; 2011 Jan; 185(1):132-7. PubMed ID: 21074211
[TBL] [Abstract][Full Text] [Related]
20. Patient opinions on prostate cancer screening are swayed by the United States Preventative Services Task Force recommendations.
Maurice MJ; Abouassaly R
Urology; 2014 Aug; 84(2):295-9. PubMed ID: 24929945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
